Intended for healthcare professionals


China vows to clamp down on academic fraud amid medical journal scandal

BMJ 2017; 357 doi: (Published 19 June 2017) Cite this as: BMJ 2017;357:j2970
  1. Jane Parry
  1. Hong Kong

China’s Ministry of Science and Technology has said that it is investigating the case of 107 papers from China retracted by the journal Tumor Biology in April this year and that it has “zero tolerance” for academic fraud. The papers were retracted after the journal’s publisher, Springer, conducted a manual screening that showed that the authors had submitted papers with fake email addresses for reviewers.

“The incident has had a very bad influence, seriously tarnishing the international reputation of China’s scientific …

View Full Text

Log in

Log in through your institution


* For online subscription